Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer disease
type: CreativeWork
author: Zhou, Bin
language: eng
date published: 2009-05-25
date modified: 2026-07-24T02:48:04Z
provider: Kyoto University
publisher: Networked Digital Library of Theses and Dissertations
type: WebPage
source organization: Kyoto University

PropertyValue
property ID: Handle
value: http://hdl.handle.net/2433/126429